NSG5140 Week 5 Midterm Exam Due 30th September Complete
Actual Exam - 200 Questions and Answers Already Graded A+
Premium Exam Tested And Verified
Subject Area Advanced Pharmacology and Pathophysiology for Nurse Practitioners
Description This midterm examination assesses advanced knowledge of
pharmacotherapeutics, pathophysiology, and clinical decision-making across
major body systems. Emphasis is placed on evidence-based prescribing, drug
interactions, adverse effects, and patient-specific considerations in primary and
acute care settings.
Expected Grade A+
Total Questions 200
Duration 3 hours
Learning Outcomes 1. Analyze pharmacokinetic and pharmacodynamic principles to optimize drug
therapy.
2. Evaluate pathophysiological mechanisms underlying common acute and
chronic conditions.
3. Select appropriate pharmacologic interventions based on patient-specific factors
and current guidelines.
4. Identify and manage potential adverse drug reactions and interactions.
5. Integrate evidence-based practice into prescribing decisions for diverse patient
populations.
Accreditation This exam aligns with standards from the American Association of Colleges of
Nursing (AACN) Essentials and the National Organization of Nurse Practitioner
Faculties (NONPF).
Page 1
,ati. NSG5140 Week 5 Midterm Exam Due 30th September Complete Actual Exam - 200
Questions and Answers Already Graded A+ Premium Exam Tested And Verified
Question: 1 of 200
A patient with type 2 diabetes and chronic kidney disease stage 3 (eGFR 45
mL/min/1.73m²) is being initiated on an SGLT2 inhibitor. Which of the following is the
most critical monitoring parameter to assess before and during therapy?
Serum potassium levels
Hemoglobin A1c
Urine albumin-to-creatinine ratio
Liver function tests
PREVIOUS
Question: 2 of 200
Which of the following best explains the synergistic effect of combining a loop diuretic
with a thiazide diuretic in a patient with refractory heart failure?
Loop diuretics block the Na-K-2Cl cotransporter in the distal convoluted tubule, while thiazides
block the Na-Cl cotransporter in the thick ascending limb.
Thiazides cause distal tubular blockade, preventing compensatory reabsorption of sodium when
loop diuretics inhibit the ascending limb.
Loop diuretics increase renal blood flow, enhancing the delivery of thiazides to their site of
action.
Thiazides inhibit carbonic anhydrase, increasing bicarbonate excretion and potentiating the
effect of loop diuretics.
PREVIOUS
Page 2
,ati. NSG5140 Week 5 Midterm Exam Due 30th September Complete Actual Exam - 200
Questions and Answers Already Graded A+ Premium Exam Tested And Verified
Question: 3 of 200
A patient with a history of recurrent Clostridioides difficile infection (CDI) is prescribed
fidaxomicin. How does fidaxomicin's mechanism of action reduce the risk of
recurrence compared to vancomycin?
It inhibits bacterial RNA polymerase, leading to selective activity against C. difficile and minimal
disruption of the gut microbiome.
It is a narrow-spectrum macrolide that inhibits protein synthesis, sparing Bacteroides species.
It inhibits cell wall synthesis and has a shorter half-life, reducing systemic exposure.
It is a prodrug that is activated only in the colon, thereby reducing systemic side effects.
PREVIOUS
Question: 4 of 200
A patient with major depressive disorder has been on fluoxetine 40 mg daily for 8
weeks with minimal improvement. The decision is made to switch to a different
antidepressant. Which of the following strategies requires the longest washout period
to avoid serotonin syndrome?
Discontinue fluoxetine and start phenelzine immediately.
Discontinue fluoxetine and start venlafaxine after a 7-day washout.
Discontinue fluoxetine and start sertraline after a 14-day washout.
Discontinue fluoxetine and start mirtazapine after a 24-hour washout.
PREVIOUS
Page 3
, ati. NSG5140 Week 5 Midterm Exam Due 30th September Complete Actual Exam - 200
Questions and Answers Already Graded A+ Premium Exam Tested And Verified
Question: 5 of 200
In a patient with acute respiratory distress syndrome (ARDS) undergoing
lung-protective ventilation, which of the following best describes the rationale for
using a low tidal volume (6 mL/kg predicted body weight) strategy?
It reduces alveolar dead space by preventing overdistension of normal alveoli.
It minimizes ventilator-induced lung injury by reducing alveolar stretch and inflammation.
It improves oxygenation by increasing mean airway pressure and recruiting collapsed alveoli.
It decreases cardiac output, thereby reducing pulmonary edema formation.
PREVIOUS
Question: 6 of 200
A patient with atrial fibrillation is started on apixaban for stroke prevention. Which of
the following statements accurately reflects the pharmacologic properties of
apixaban?
It directly inhibits thrombin, requiring no monitoring of coagulation parameters.
Its bioavailability is dose-dependent, with higher doses showing decreased absorption.
It is a substrate of CYP3A4 and P-glycoprotein, making it susceptible to drug interactions with
strong inhibitors of these pathways.
It has a half-life of approximately 12 hours, necessitating twice-daily dosing to maintain
therapeutic levels.
PREVIOUS
Page 4
Actual Exam - 200 Questions and Answers Already Graded A+
Premium Exam Tested And Verified
Subject Area Advanced Pharmacology and Pathophysiology for Nurse Practitioners
Description This midterm examination assesses advanced knowledge of
pharmacotherapeutics, pathophysiology, and clinical decision-making across
major body systems. Emphasis is placed on evidence-based prescribing, drug
interactions, adverse effects, and patient-specific considerations in primary and
acute care settings.
Expected Grade A+
Total Questions 200
Duration 3 hours
Learning Outcomes 1. Analyze pharmacokinetic and pharmacodynamic principles to optimize drug
therapy.
2. Evaluate pathophysiological mechanisms underlying common acute and
chronic conditions.
3. Select appropriate pharmacologic interventions based on patient-specific factors
and current guidelines.
4. Identify and manage potential adverse drug reactions and interactions.
5. Integrate evidence-based practice into prescribing decisions for diverse patient
populations.
Accreditation This exam aligns with standards from the American Association of Colleges of
Nursing (AACN) Essentials and the National Organization of Nurse Practitioner
Faculties (NONPF).
Page 1
,ati. NSG5140 Week 5 Midterm Exam Due 30th September Complete Actual Exam - 200
Questions and Answers Already Graded A+ Premium Exam Tested And Verified
Question: 1 of 200
A patient with type 2 diabetes and chronic kidney disease stage 3 (eGFR 45
mL/min/1.73m²) is being initiated on an SGLT2 inhibitor. Which of the following is the
most critical monitoring parameter to assess before and during therapy?
Serum potassium levels
Hemoglobin A1c
Urine albumin-to-creatinine ratio
Liver function tests
PREVIOUS
Question: 2 of 200
Which of the following best explains the synergistic effect of combining a loop diuretic
with a thiazide diuretic in a patient with refractory heart failure?
Loop diuretics block the Na-K-2Cl cotransporter in the distal convoluted tubule, while thiazides
block the Na-Cl cotransporter in the thick ascending limb.
Thiazides cause distal tubular blockade, preventing compensatory reabsorption of sodium when
loop diuretics inhibit the ascending limb.
Loop diuretics increase renal blood flow, enhancing the delivery of thiazides to their site of
action.
Thiazides inhibit carbonic anhydrase, increasing bicarbonate excretion and potentiating the
effect of loop diuretics.
PREVIOUS
Page 2
,ati. NSG5140 Week 5 Midterm Exam Due 30th September Complete Actual Exam - 200
Questions and Answers Already Graded A+ Premium Exam Tested And Verified
Question: 3 of 200
A patient with a history of recurrent Clostridioides difficile infection (CDI) is prescribed
fidaxomicin. How does fidaxomicin's mechanism of action reduce the risk of
recurrence compared to vancomycin?
It inhibits bacterial RNA polymerase, leading to selective activity against C. difficile and minimal
disruption of the gut microbiome.
It is a narrow-spectrum macrolide that inhibits protein synthesis, sparing Bacteroides species.
It inhibits cell wall synthesis and has a shorter half-life, reducing systemic exposure.
It is a prodrug that is activated only in the colon, thereby reducing systemic side effects.
PREVIOUS
Question: 4 of 200
A patient with major depressive disorder has been on fluoxetine 40 mg daily for 8
weeks with minimal improvement. The decision is made to switch to a different
antidepressant. Which of the following strategies requires the longest washout period
to avoid serotonin syndrome?
Discontinue fluoxetine and start phenelzine immediately.
Discontinue fluoxetine and start venlafaxine after a 7-day washout.
Discontinue fluoxetine and start sertraline after a 14-day washout.
Discontinue fluoxetine and start mirtazapine after a 24-hour washout.
PREVIOUS
Page 3
, ati. NSG5140 Week 5 Midterm Exam Due 30th September Complete Actual Exam - 200
Questions and Answers Already Graded A+ Premium Exam Tested And Verified
Question: 5 of 200
In a patient with acute respiratory distress syndrome (ARDS) undergoing
lung-protective ventilation, which of the following best describes the rationale for
using a low tidal volume (6 mL/kg predicted body weight) strategy?
It reduces alveolar dead space by preventing overdistension of normal alveoli.
It minimizes ventilator-induced lung injury by reducing alveolar stretch and inflammation.
It improves oxygenation by increasing mean airway pressure and recruiting collapsed alveoli.
It decreases cardiac output, thereby reducing pulmonary edema formation.
PREVIOUS
Question: 6 of 200
A patient with atrial fibrillation is started on apixaban for stroke prevention. Which of
the following statements accurately reflects the pharmacologic properties of
apixaban?
It directly inhibits thrombin, requiring no monitoring of coagulation parameters.
Its bioavailability is dose-dependent, with higher doses showing decreased absorption.
It is a substrate of CYP3A4 and P-glycoprotein, making it susceptible to drug interactions with
strong inhibitors of these pathways.
It has a half-life of approximately 12 hours, necessitating twice-daily dosing to maintain
therapeutic levels.
PREVIOUS
Page 4
